PRF Technologies to Establish GridFeed as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Trading Platform Life Science Investing
Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer Life Science Investing
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York Medical Device Investing
National Coalition of Pharmaceutical Industry, Academic, and Nonprofit Partners Launches Fifth Winn CIPP Cohort Life Science Investing
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026 Life Science Investing
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment Life Science Investing
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism Life Science Investing
Compass Pathways' New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year Psychedelics Investing
